Bal Pharma receives revision in credit ratings from ICRA

Bal Pharma has received upgrade in credit ratings from ICRA as under -

Long term fund based facilities - ICRA BB reaffirmed; Outlook revised to Stable from Negative.

Short term fund non fund based facilities - ICRA A4 reaffirmed

Long term - term loan - ICRA BB; Outlook revised to Stable from Negative.

Powered by Capital Market - Live News